GENPHARMASEC
|
GENPHARMASEC Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Profit Before Tax | ₹1.88 Cr | ₹0.25 Cr | ₹0.28 Cr |
| Adjustment | ₹-1.04 Cr | ₹0.39 Cr | ₹0.16 Cr |
| Changes In working Capital | ₹2.22 Cr | ₹-3.54 Cr | ₹-3.77 Cr |
| Cash Flow after changes in Working Capital | ₹3.06 Cr | ₹-2.90 Cr | ₹-3.32 Cr |
| Cash Flow from Operating Activities | ₹2.99 Cr | ₹-2.95 Cr | ₹-3.06 Cr |
| Cash Flow from Investing Activities | ₹-15 Cr | ₹-28 Cr | ₹0.36 Cr |
| Cash Flow from Financing Activities | ₹-1.25 Cr | ₹48 Cr | ₹3.08 Cr |
| Net Cash Inflow / Outflow | ₹-14 Cr | ₹17 Cr | ₹0.39 Cr |
| Opening Cash & Cash Equivalents | ₹19 Cr | ₹1.99 Cr | ₹1.61 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - |
| Effect of Foreign Exchange Fluctuations | - | - | - |
| Closing Cash & Cash Equivalent | ₹5.27 Cr | ₹19 Cr | ₹1.99 Cr |
Compare Cashflow Statement of peers of GENPHARMASEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENPHARMASEC | ₹64.8 Cr | -7.2% | -14.1% | -60.7% | Stock Analytics | |
| SUDARSHAN CHEMICAL INDUSTRIES | ₹7,117.5 Cr | -2.6% | -6.7% | -18.9% | Stock Analytics | |
| KIRI INDUSTRIES | ₹2,788.1 Cr | -2.3% | -22.9% | -16.3% | Stock Analytics | |
| VIDHI SPECIALTY FOOD INGREDIENTS | ₹1,562.0 Cr | 1.7% | -7.6% | -39.8% | Stock Analytics | |
| SHREE PUSHKAR CHEMICALS & FERTILISERS | ₹1,060.5 Cr | -8.7% | -14.6% | 12.9% | Stock Analytics | |
| BODAL CHEMICALS | ₹603.3 Cr | 0.8% | -11.4% | -24% | Stock Analytics | |
GENPHARMASEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENPHARMASEC | -7.2% |
-14.1% |
-60.7% |
| SENSEX | 0.8% |
-2.9% |
8.1% |
You may also like the below Video Courses